Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
70<br />
<strong>Solvay</strong> Global Annual Report 2005<br />
Reconciliation of the tax charge<br />
The effective tax charge has been reconciled with the theoretical tax charge obtained by applying to the pre-tax<br />
profi t of each Group entity the nominal tax rate prevailing in the country in which it operates.<br />
EUR Million 2004 2005<br />
Profi t before income taxes 600 493 (1)<br />
Reconciliation of the tax charge<br />
Total tax charge of the Group entities computed on the basis of the respective local<br />
nominal rates<br />
-204 -150<br />
Weighted average nominal rate 34 % 30 %<br />
Tax effect of non-deductible expenses -75 -112<br />
Tax effect of tax-exempt revenues 127 98<br />
Tax effect of changes in tax rates 4 0<br />
Tax effect of current and deferred tax adjustments related to prior years -9 28<br />
Valuation allowance on deferred tax assets 32 -17<br />
Effective tax charge -125 -153<br />
(1) Profi t before income taxes = Net income of the Group - net income from discontinued operations + income taxes.<br />
Analysis of the past year’s tax charge<br />
The Group’s effective tax rate is higher than the weighted average nominal rate, having been negatively infl uenced by<br />
the provision for non tax-deductible charges. In 2004 the same fi gure was favorably infl uenced by the recognition of<br />
EUR 63 million deferred tax asset in Germany.<br />
Deferred taxes on the balance sheet<br />
Deferred tax assets and liabilities are recorded in the balance sheet in respect of temporary differences arising from<br />
the fact that the tax authorities apply different rules when assessing assets and liabilities than those used for drawing<br />
up annual accounts. Variations occurring during the year in the deferred taxes recorded in the balance sheet are<br />
taken into income, except where they relate to items that are recorded directly in shareholders’ equity (cf. above).<br />
Deferred taxes are calculated based on the prevailing tax rates, or where they have been changed, at the enacted<br />
rates that are expected to apply at the time of recording the taxes payable (or recoverable) in the statutory accounts.<br />
Deferred tax assets are written down to the extent that it appears unlikely, in the light of expected future tax<br />
situations, that they will in the future generate either a reduction in the tax base or tax credits.<br />
Unless a dividend payment is planned, no deferred tax is calculated on the undistributed profi ts of subsidiaries as<br />
these profi ts are, as a general rule, reinvested locally.